No Prescription |
 |
 | ||
|
RETINO A Avita |
|
| ||
No Prescription » Prescription Drugs 14 » RETINO A Avita Tretinoin is used to treat acne. It promotes peeling of affected skin areas and unclogs pores. Tretinoin controls acne but does not cure it.Tretinoin comes in topical liquid cream and gel. Tretinoin usually is used daily at bedtime or once every 2 or 3 days. Follow the directions on your prescription label carefully and ask your doctor or pharmacist to explain any part you do not understand. Use tretinoin exactly as directed. Do not use more or less of it or use it more often than prescribed by your doctor.Your acne probably will get worse (red scaling skin and an increase in acne sores) during the first 7-10 days that you use this medication. Nevertheless continue to use it; the acne sores should disappear. Usually 2-3 weeks (and sometimes more than 6 weeks) of regular use of tretinoin is required before improvement is seen.Use only nonmedicated cosmetics on cleansed skin. Do not use topical preparations with a lot of alcohol menthol spices or lime (e.g. shaving lotions astringents and perfumes); they can sting your skin especially when you first use tretinoin.Do not use any other topical medications especially benzoyl peroxide salicylic acid (wart remover) and dandruff shampoos containing sulfur or resorcinol unless your doctor directs you to do so. If you have used any of these topical medications recently ask your doctor if you should wait before using tretinoin. Buy RETINO A Avita and other Prescription Drugs 14 products online at Medstore. Buy Online at Medstore - Click Here!
About RETINO A Avita: Product Type: Prescription Drugs 14 RETINO-A ( Avita Renova Retin-A Generic Tretinoin ) RETINO-A (Avita Renova Retin-A Generic Tretinoin) Avita Renova Retin-A Generic Tretinoin Cream 0.025% Avita Renova Retin-A Generic Tretinoin RETINO-A
View more Prescription Drugs 14 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
